Background Cardiovascular disease (CVD) is the most common complication of diabetes mellitus (DM). To prevent morbidity and mortality among patients with type 2 diabetes mellitus (T2DM), optimization of glycemic status and minimizing CVD risk factors is essential. As Nepal has limited data on these CVD risk parameters, we assessed the prevalence of poor glycemic control, CVD risk factors, and their clustering among patients with T2DM. Methods Using a cross-sectional study design, we collected data of 366 patients with T2DM. We applied a multistage cluster sampling technique and used the WHO STEPS tools. Binary logistic and Poisson regression was applied to calculate odds and prevalence ratio of clustering of risk factors, considering P< 0.05 statistically significant. Results The mean age of participants was 54.5±10.7 years and 208 (57%) were male. The prevalence of poor glycemic control was 66.4% (95% C.I: 61.5–71.2). The prevalence of smoking, alcohol users, inadequate fruit and vegetables intake and physical inactivity were 18% (95% C.I:14 to 21.9), 14.8% (95% C.I:11.1 to 18.4), 98.1% (95% C.I: 96.7–99.4), and 9.8% (95% C.I:6.7–12.8), respectively. Overall, 47.3% (95% C.I: 42.1–52.4) were overweight and obese, 59% (95% C.I: 52.9–63) were hypertensive, and 68% (95% C.I: 63.2–72.7) had dyslipidemia. Clustering of two, three, four, five and more than five risk factors was 12.6%, 30%, 30%,19%, and 8.7%, respectively. Four or more risk factors clustering was significantly associated with gender, age, level of education, T2DM duration, and use of medication. Risk factors clustering was significantly higher among males and users of anti-diabetic medications with prevalence ratio of 1.14 (95% C.I:1.05–1.23) and 1.09 (95% C.I: 1.09–1.18)], respectively. Conclusions The majority of the patients with T2DM had poor glycemic control and CVD risk factors. Policies and programs focused on the prevention and better management of T2DM and CVD risk factors should be implemented to reduce mortality in Nepal.
The 2022 Federation Internationale de Football Association (FIFA) World Cup will take place in Qatar and will be a one-of-a-kind mega-crowd gathering. This is the first time in history that people from all over the world would gather in such a concentrated place. There is a higher chance of spreading zoonotic illnesses from one community to another among those who travel internationally, therefore tourists should be aware of the dangers they may face and take precautions. The public health system of the country hosting the event must be equipped to avoid the spread of zoonotic diseases considering the current global climate. The potential for an increase in cases of COVID-19 and monkeypox is notably heightened by this event. Possible exotic diseases such as the Marburg virus disease could also be spread. Due to Qatar’s inexperience in hosting such major events, it is crucial to invest heavily in training for the early identification of infectious illnesses and the prevention of their spread among event attendees. Visitors to Qatar 2022 should acquire the most up-to-date information available and be aware of the usual precautions that should be followed. Your immunization record must be up to date. Hospitals and other medical facilities in Qatar would be wise to increase their readiness for mass casualty occurrences given that this small location is hosting such an event for the first time. To better meet the health needs of its population, the government of Qatar should promote health advice materials in different languages and keep an adequate supply on hand. The potential for the emergence of zoonotic diseases is briefly reviewed here considering the upcoming FIFA World Cup in 2022.
Diabetic foot ulcers (DFUs) are the results of the combined effects of diabetes-related vascular disease and neuropathy. DFUs are responsible for more hospitalizations than any other complication of diabetes. It can impair patients’ quality of life and affect social participation and livelihood. It is one of the big challenges for podiatric surgeons to salvage the foot upto optimum. A case of DFU of a patient of 70 years of age with repeated history of Ray’s Amputation was managed by an integrated approach (Ayurveda and Allopathy medications and procedures).
Thromboangitis Obliterans (TAO) is a non-atherosclerotic inflammatory disorder of unknown etiology that affects small and medium-sized vessels of the extremities and has a strong association with smoking.The clinical criteria include: age under 45 years; current or recent history of tobacco use; presence of distal-extremity ischemia indicated by claudication, pain at rest, ischemic ulcers or gangrenes and documented by non-invasive vascular testing.A diagnosed case of TAO with gangrene on right great toe with post lumbar sympathectomy status was admitted for severe pain on right lower limb.Ayurvedic Enema therapy (Manjisthadi Kshara Basti) for 30 days (Karma Basti) was given for the patient who resulted in significant clinical improvement on the pain and subsequent healing of ulcer.Oil based enema made up Rubia cordifolia and other ingredients (Manjisthadi Taila) and Alkali Based Enema therapy (Kshara Basti) mixed with Manjishthadi Kwatha (decoction of Rubia cordifolia and other ingredients) was executed here on alternate days and has shown significant results on the pain, claudication distance etc.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.